Literature DB >> 29680745

Clonorchis sinensis cyclophilin A immunization protected mice from CLP-induced sepsis.

Juan Jiang1, Hongling Yin1, Yao Sun2, Huaiqiu Huang3, Xuchu Hu4.   

Abstract

Cyclophilin A (CyPA), ubiquitously existing in cytoplasm of all eukaryotes, can be secreted in response to inflammatory stimuli. Extracellular CyPA plays a prominent role in the pathological processes of inflammatory diseases, acting as a proinflammatory mediator, exerting chemotactic effects, promoting apoptosis of endothelial cells and amplifying ROS generation, thus being considered as a potential treatment target of sepsis, a systemic inflammatory response syndrome. Our previous study found that antibodies against cyclophilin A of Clonorchis sinensis (CsCyPA) could neutralize mouse cyclophilin A (MuCyPA). In this study, we explored whether CsCyPA immunization could prevent or ameliorate mice sepsis induced by cecum ligation puncture (CLP). The results showed that CsCyPA immunization could improve the 72 h survival rate of mice after CLP. Moreover, the protective effect presented in a titer-dependent manner. The levels of cytokine IL-1β, IL-6, TNF-α, MCP-1 and AST in serum were remarkably decreased compared to CLP control group mice. Pathological damages of liver, lung and kidney were ameliorated accompanied by less inflammatory cell infiltration. CFU per whole peripheral blood at 12 h and 24 h after CLP surgery was significantly lower than that of CLP control group. In vitro, intracellular ROS generation and cytokine mRNA expression in peritoneal macrophages stimulated by LPS were reduced obviously with anti-CsCyPA antibodies (anti-CsCyPAs) preincubation. All these results demonstrated that CsCyPA immunization protected mice from CLP induced sepsis.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Antibody; Clonorchis sinensis; Cyclopholin A (CyPA); Immunization; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 29680745     DOI: 10.1016/j.intimp.2018.03.039

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  5 in total

1.  [Protective effect of excretory-secretory proteins from Trichinella spiralis muscle larvae against myocardial injury in septic mice].

Authors:  Y Yuan; F Nian; H Li; H Yang; Y Wu; M Ma; K Wang; X Chen; Z Zhang; G Li; X Yang; Q Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

2.  Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production.

Authors:  Xin-Tong Wang; Zhen Peng; Ying-Ying An; Ting Shang; Guangxu Xiao; Shuang He; Xi Chen; Han Zhang; Yuefei Wang; Tao Wang; Jun-Hua Zhang; Xiumei Gao; Yan Zhu; Yuxin Feng
Journal:  Front Pharmacol       Date:  2021-04-13       Impact factor: 5.810

Review 3.  Cyclophilin A: a key player for etiological agent infection.

Authors:  Yating Liao; Dan Luo; Kailan Peng; Yanhua Zeng
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-25       Impact factor: 5.560

4.  Schistosoma japonicum Cystatin Alleviates Sepsis Through Activating Regulatory Macrophages.

Authors:  Hong Xie; Lingqin Wu; Xingzhi Chen; Shifang Gao; Huihui Li; Yuan Yuan; Jinbao Liang; Xiaoli Wang; Shuying Wang; Changyan Xu; Liang Chu; Bin Zhan; Rui Zhou; Xiaodi Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

5.  The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?

Authors:  Pengfei Cai; Yi Mu; Donald P McManus
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.